Prevention of cerebrovascular spasms with nimodipine.
Fleckenstein-Grün
G
G
Physiological Institute, University of Freiberg, FRG.
Fleckenstein
A
A
D000818:Animals; D001488:Basilar Artery / Q000187:drug effects / Q000502:physiology; D001921:Brain / Q000098:blood supply; D002118:Calcium / Q000378:metabolism; D003331:Coronary Vessels / Q000187:drug effects / Q000502:physiology; D006168:Guinea Pigs; D006461:Hemolysis; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D009200:Myocardial Contraction / Q000187:drug effects; D009553:Nimodipine / Q000494:pharmacology / Q000627:therapeutic use*; D010210:Papillary Muscles / Q000187:drug effects / Q000502:physiology; D011188:Potassium / Q000494:pharmacology; D012077:Renal Artery / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000494:pharmacology; D013552:Swine; D014661:Vasoconstriction / Q000187:drug effects
D012701:Serotonin; D009553:Nimodipine; D011188:Potassium; D002118:Calcium